Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug

Pharmaceutical Research

Volumn 27, Issue 11, 2010, Pages 2466-2477

  Yu, Deng Guang ^a   Gao, Li Dong ^b   White, Kenneth ^c   Branford White, Christopher ^c   Lu, Wei Yue ^d   Zhu, Li Min ^a  

^a DONGHUA UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^c LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^d FUDAN UNIVERSITY   (China)

Author keywords

amorphous nanofibers; dissolution; elevated temperature electrospinning; permeation; poorly soluble drugs

Indexed keywords

DODECYL SULFATE SODIUM; MANNITOL; NANOFIBER; POLYMER; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; COMPOSITE MATERIAL; CONTROLLED STUDY; DISSOLUTION; DRUG SOLUBILITY; ELECTROSPINNING; HIGH TEMPERATURE; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; STATIC ELECTRICITY; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SOLUTIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER; X-RAY DIFFRACTION;

EID: 78549245541     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0239-y     Document Type: Article

References (42)

1. B Tang G Cheng JC Gu CH Xu 2008 Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms Drug Discov Today 13 606 612 1:CAS:528:DC%2BD1cXotlClsr8%3D 10.1016/j.drudis.2008.04.006 18598917
2. N Rasenack BW Muller 2002 Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs Pharm Res. 19 1894 1900 1:CAS:528:DC%2BD38XpsVSjsbY%3D 10.1023/A:1021410028371 12523671 (Pubitemid 36016039)
3. T Vasconcelos B Sarmento P Costa 2007 Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov Today 12 1068 1075 1:CAS:528:DC%2BD2sXhsVSmurnF 10.1016/j.drudis.2007.09.005 18061887 (Pubitemid 350186132)
4. N Blagden M de Matas PT Gavan P York 2007 Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Adv Drug Del Rev. 59 617 630 1:CAS:528:DC%2BD2sXpsFGks7w%3D 10.1016/j.addr.2007.05.011 (Pubitemid 47285407)
5. E Merisko-Liversidge GG Liversidge ER Cooper 2003 Nanosizing: a formulation approach for poorly-water-soluble compounds Eur J Pharm Sci. 18 113 120 1:CAS:528:DC%2BD3sXht1Kltrg%3D 10.1016/S0928-0987(02)00251-8 12594003 (Pubitemid 36184748)
6. OC Farokhzad 2008 Nanotechnology for drug delivery: the perfect partnership Expert Opin Drug Del. 5 927 929 1:CAS:528:DC%2BD1cXhtVGktrnI 10.1517/17425247.5.9.927
7. OC Farokhzad R Langer 2009 Impact of Nanotechnology on Drug Delivery ACS Nano. 3 16 20 1:CAS:528:DC%2BD1MXnvFGisQ%3D%3D 10.1021/nn900002m 19206243
8. AA Moshfeghi GA Peyman 2005 Micro- and nanoparticulates Adv Drug Deliv Rev. 57 2047 2052 1:CAS:528:DC%2BD2MXht12ksb%2FN 10.1016/j.addr.2005.09.006 16298454 (Pubitemid 41740795)
9. E Merisko-Liversidge SL McGurk GG Liversidge 2004 Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin Pharm Res. 21 1545 1553 1:CAS:528:DC%2BD2cXnsFyjsbo%3D 10.1023/B:PHAM.0000041446.14569.e2 15497677 (Pubitemid 41184382)
10. L Yin J Ding C He L Cui C Tang C Yin 2009 Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery Biomaterials. 30 5691 5700 1:CAS:528:DC%2BD1MXpvFCnsr8%3D 10.1016/j.biomaterials.2009.06.055 19615735
11. H Li X Zhao Y Ma G Zhai L Li H Lou 2009 Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles J Control Release 133 238 244 1:CAS:528:DC%2BD1MXpsF2kuw%3D%3D 10.1016/j.jconrel.2008.10.002 18951932
12. P Li SR Hynes TF Haefele M Pudipeddi AE Royce AT Serajuddin 2009 Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug J Pharm Sci. 98 1750 1764 1:CAS:528:DC%2BD1MXlsFyqtrw%3D 10.1002/jps.21547 18781639
13. E Merisko-Liversidge GG Liversidge 2008 Drug nanoparticles: formulating poorly water-soluble compounds Toxicol Pathol. 36 43 48 1:CAS:528: DC%2BD1cXkslKgsL8%3D 10.1177/0192623307310946 18337220
14. GL Amidon H Lennernäs VP Shah JR Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res. 12 413 420 1:CAS:528:DyaK2MXksVGqur8%3D 10.1023/A:1016212804288 7617530
15. DG Yu XX Shen C Branford-White K White LM Zhu SWA Bligh 2009 Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers Nanotechnology 20 055104 10.1088/0957-4484/20/5/055104 19417335
16. DG Yu C Branford-White K White XL Li LM Zhu 2010 Comparison of solid dispersions in drug delivery membranes from different processes AAPS PharmSciTech. 11 809 817 1:CAS:528:DC%2BC3cXptVeqt7c%3D 10.1208/s12249-010-9438- 4 20446072
17. DG Yu C Branford-White L Li XM Wu LM Zhu 2010 The compatibility of acyclovir with the matrix polymer PAN in the electrospun nanofiber membrane J Applied Polym Sci. 117 1509 1515 1:CAS:528:DC%2BC3cXmt12qsr0%3D
18. DG Yu LM Zhu K White C Branford-White 2009 Electrospun nanofiber-based drug delivery systems Health 1 67 75 10.4236/health.2009.12012
19. MG McKee JM Layman MP Cashion EL Timothy 2006 Phospholipid nonwoven electrospun membranes Science. 311 353 355 1:CAS:528:DC%2BD28XlvFShuw%3D%3D 10.1126/science.1119790 16424332 (Pubitemid 43132654)
20. Y Dzenis 2004 Spinning continuous fibres for nanotechnology Science 304 1917 1919 1:CAS:528:DC%2BD2cXlt1Wrsr4%3D 10.1126/science.1099074 15218134 (Pubitemid 38822175)
21. GC Rutledge SV Fridrikh 2007 Formation of fibers by electrospinning Adv Drug Del Rev. 59 1384 1391 1:CAS:528:DC%2BD2sXhtlCrtr7I 10.1016/j.addr.2007.04. 020 (Pubitemid 350122769)
22. L Ji C Saquing SA Khan X Zhang 2008 Preparation and characterization of silica nanoparticulate-polyacrylonitrile composite and porous nanofibers Nanotechnology 19 085605 10.1088/0957-4484/19/8/085605 (Pubitemid 351225315)
23. DY Liu GL Wang SC Ma RC Lin 2004 Research on the pharmaceutical active components in Helicia Lour Chin Tradit Herbal Drugs 35 593 595 1:CAS:528:DC%2BD2MXmvVWjtLk%3D
24. DG Yu XL Yang Y Wang X Li HB Xu 2007 3DP used for controlled-release helicid tablets Chin Tradit Patent Med. 29 679 683 1:CAS:528: DC%2BD2sXms1eksbs%3D
25. G Chawla AK Bansal 2008 Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives Acta Pharm. 58 257 274 1:CAS:528:DC%2BD1cXht1ygt7nF 10.2478/v10007-008-0016-1 19103563
26. K Whitehea N Karr S Mitragotri 2008 Safe and effective permeation enhancers for oral drug delivery Pharm Res. 25 1782 1788 10.1007/s11095-007- 9488-9
27. A Pongpeerapat C Wanawongthai Y Tozuka K Moribe K Ymamoto 2008 Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture Int J Pharm. 352 309 316 1:CAS:528:DC%2BD1cXitlWht7s%3D 10.1016/j.ijpharm.2007.10.052 18162340
28. C Wanawongthai A Pongpeerapat K Higashi Y Tozuka K Moribea K Yamamoto 2009 Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture Int J Pharm. 376 169 175 1:CAS:528:DC%2BD1MXntFyntrk%3D 10.1016/j.ijpharm.2009.04.034 19409462
29. D Li Y Xia 2004 Electrospinning of nanofibers: reinventing the wheel? Adv Mater. 16 1151 1170 1:CAS:528:DC%2BD2cXmvFOhs7s%3D 10.1002/adma.200400719
30. C Wang HS Chien CH Hsu YC Wang CT Wang HA Lu 2007 Electrospinning of polyacrylonitrile solutions at elevated temperatures Macromolecules 40 7973 7983 1:CAS:528:DC%2BD2sXhtFWgu73K 10.1021/ma070508n (Pubitemid 350099702)
31. SR Givens KH Gardner JF Rabolt DB Chase 2007 High-temperature electrospinning of polyethylene microfibers from solution Macromolecules 40 608 610 1:CAS:528:DC%2BD28XhtlCqtrvK 10.1021/ma062398a
32. NR Jadhav VL Gaikwad KJ Nair HM Kadam 2009 Glass transition temperature: basics and application in pharmaceutical sector Asian J Pharm. 3 82 89 10.4103/0973-8398.55043
33. MG McKee CL Elkins TE Long 2004 Influence of self-complementary hydrogen bonding on solution rheology/electrospinning relationships Polymer 45 8705 8715 1:CAS:528:DC%2BD2cXhtVWgtrjJ 10.1016/j.polymer.2004.10.049 (Pubitemid 39550607)
34. NS Murthy H Minor C Bednarczyk S Krimm 1993 Structure of the amorphous phase in oriented polymers Macromolecules 26 1712 1721 1:CAS:528: DyaK3sXhsVygsbo%3D 10.1021/ma00059a034
35. A Pongpeerapat K Higashi Y Tozuka K Moribe K Yamamoto 2006 Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR Pharm Res. 23 2566 2574 1:CAS:528:DC%2BD28XhtFKgu7nN 10.1007/s11095-006-9089-z 16969700 (Pubitemid 44691603)
36. P Roscigno F Asaro G Pellizer O Ortana L Paduano 2003 Complex Formation between PVP and sodium decyl sulfate Langmiur 19 9638 9644 1:CAS:528: DC%2BD3sXnvFOiurY%3D 10.1021/la034928r
37. G Verreck I Chun J Peeters J Rosenblatt ME Brewster 2003 Preparation and characterization of nanofibers containing amorphous drug dispersion generated by electrostatic spinning Pharm Res. 20 810 817 1:CAS:528:DC%2BD3sXjtFKgsLY%3D 10.1023/A:1023450006281 12751639 (Pubitemid 36515316)
38. AN Ghebremeskel C Vemavarapu M Lodaya 2007 Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability Int J Pharm. 328 119 129 1:CAS:528:DC%2BD28XhtlWqurnF 10.1016/j.ijpharm.2006.08.010 16968659 (Pubitemid 44895482)
39. T Goswami BR Jasti X Li 2009 Estimation of the theoretical pore sizes of the porcine oral mucosa for permeation of hydrophilic permeants Arch Oral Biol. 54 577 582 1:CAS:528:DC%2BD1MXmtlKksro%3D 10.1016/j.archoralbio.2009.03.001 19344889
40. MK Dhiman A Dhiman KK Sawant 2009 Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study AAPS PharmSciTech 10 258 265 1:CAS:528:DC%2BC3cXotV2murg%3D 10.1208/s12249-009-9203-8 19280347
41. DJ Chett LH Chen YW Chien 2001 Characterization of captopril sublingual permeation of preferred routes and mechanisms J Pharm Sci. 90 1868 1877 10.1002/jps.1136 (Pubitemid 33062607)
42. JA Nicolazzo BL Reed BC Finnin 2005 Buccal penetration enhancers-How do they really work? J Control Release. 105 1 15 1:CAS:528:DC%2BD2MXlt1Smtb4%3D 10.1016/j.jconrel.2005.01.024 15894393 (Pubitemid 40805471)